Archives

  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Two separate experiments were done

    2018-11-07

    Two separate experiments were done: one with IL-1β and 1,25(OH)2D3 (Table 1) and the other with no stimulus, TNF-α, calcipotriol, dexamethasone and a combination of all stimuli (Table 2). PGE2 analysis was done in conjunction with the latter experiment.
    Data Five scanning purchase SL-327 microscope (SEM) images of A. flavus (before modification, after modification, after bioadsorption of Zn, after bioadsorption of Co, and after bioadsorption of Ni) are depicted in Fig. 1. The effect of pH on the bioadsorption of Ni(II), Co(II), and Zn(II) is shown in Fig. 2. Fig. 3 depicts the effect of temperature and contact time on the bioadsorption of Zn(II), Ni(II), and Co(II). The effect of bioadsorbent dosage on the metals removal is also presented in Fig. 4. The isotherm (Langmuir and Freundlich models) and kinetic (pseudo-first-order and pseudo-second-order models) parameters are shown in Table 1 and 2. The characteristics of plating wastewater before and after treatment with the prepared bioadsorbent are depicted in Table 3.
    Experimental design, materials and methods
    Acknowledgements
    Data Data relative to the population of 125 individuals monitored, previously classified as either chronic (i.e. positive) and non-chronic (i.e. negative) alcohol drinker, are available in Table 1. Analysis of likelihood ratio models and its performance metrics, such as Empirical Cross Entropy plots (ECE), allowed to compare the predictive capabilities of direct and indirect biomarkers of ethanol consumption, as described in [1].
    Experimental design, materials and methods Ethical approval for the study was granted by the Ethical Committee of the Azienda Ospedaliero-Universitaria San Luigi Gonzaga of Orbassano (Protocol Number 0012756). Serum activities of AST, ALT and GGT were measured by means of colorimetric assays with a Roche-Cobas Integra 800® auto-analyzer (Roche Diagnostic, Basel, Switzerland). MCV was measured with an ADVIA® 2120 Hematology auto-analyzer (Siemens Healthcare Diagnostic, Milan, Italy). The %CDT was determined by the HPLC reagent kit purchased by BioRad® (Munich, Germany). FAEEs were detected by HS–SPME–GC/MS analysis and a MultiPurpose Sampler Flex A05-FLX-0001 (Est Analytical, West Chester Township, OH, USA) equipped with a 65 μm StableflexTM polydimethylsiloxane/divinylbenzene fiber (PDMS/DVB) from Supelco (Sigma-Aldrich, Milan, Italy) was used in combination with a 6890N GC 5975-inert MSD (Agilent Technologies, Milan, Italy). EtG concentrations were monitored by UHPLC–MS/MS analysis and a Shimadzu Nexera UHPLC system (Shimadzu, Duisburg, Germany) interfaced to an AB Sciex API 5500 triple quadrupole mass spectrometer (AB Sciex, Darmstadt, Germany) was employed. Descriptions about the analytical methodologies utilized to detect both the direct and the indirect biomarkers are available in [1] and [4]. Base 10 logarithm transformation (log10x) was applied on the analyzed data. Before calculating the different LR models, all the variables were autoscaled and equal prior probabilities were utilized. LR evaluations (briefly represented by this formula LR=Pr(E H1)/Pr(E H2)) involved two mutually exclusive hypotheses (H1: the subject is not a chronic alcohol abuser – “negative” class; H2: the subject is a chronic alcohol abuser – “positive” class) and a reference population was used to build the model, representing the experimental evidence (E). The ECE plots relative to indirect biomarkers detected in blood samples are reported in Fig. 1. ECE plots relative to the sum of the four FAEEs and EtG are reported in [1]. Further LR models were tested combining biomarkers, providing higher performances. As an example, LR models developed taking into account all the variables simultaneously (LR8, i.e. AST, ALT, GGT, CDT, MCV, BMI, FAEEs and EtG) and a shorter list of variables (LR4, i.e. CDT, GGT, FAEEs and EtG) are shown in Fig. 2a–b. Multivariate approaches were also performed on the collected data simultaneously; Principal Components Analysis [5] (PCA, Fig. 3a) and Partial Least Squares – Discriminant Analysis [6] (PLS-DA, Fig. 3b).